Choroidal Structural Changes Correlate With Neovascular Activity in Neovascular Age Related Macular Degeneration.
暂无分享,去创建一个
J. Chhablani | M. Gillies | G. Staurenghi | A. Invernizzi | K. Vupparaboina | Mariano Cozzi | E. Benatti | S. Erba | S. Vaishnavi | F. Viola | M. Cozzi | Eleonora Benatti
[1] A. Bill,et al. Control of retinal and choroidal blood flow , 1990, Eye.
[2] C. Delaey,et al. Regulatory Mechanisms in the Retinal and Choroidal Circulation , 2000, Ophthalmic Research.
[3] E. Steuer,et al. Fluorescein angiographic lesion type frequency in neovascular age-related macular degeneration. , 2004, Ophthalmology.
[4] R. Bhisitkul. Vascular endothelial growth factor biology: clinical implications for ocular treatments , 2006, British Journal of Ophthalmology.
[5] H. Koizumi,et al. Choroidal circulatory disturbances associated with retinal angiomatous proliferation on indocyanine green angiography , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.
[6] T. Desmettre,et al. Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration , 2007, British Journal of Ophthalmology.
[7] R. Spaide,et al. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. , 2009, American journal of ophthalmology.
[8] J. Slakter,et al. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. , 2009, American journal of ophthalmology.
[9] J. Marticorena,et al. Retinal angiomatous proliferation. , 2011, Current drug targets.
[10] I. Bhutto,et al. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. , 2012, Molecular aspects of medicine.
[11] Hideki Koizumi,et al. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results. , 2012, Ophthalmology.
[12] R. Schiffelers,et al. Neovascular Age-Related Macular Degeneration , 2011, BioDrugs.
[13] K. Nishida,et al. Circadian changes in subfoveal choroidal thickness and the relationship with circulatory factors in healthy subjects. , 2012, Investigative ophthalmology & visual science.
[14] S. Kinoshita,et al. SUBFOVEAL CHOROIDAL THICKNESS IN RETINAL ANGIOMATOUS PROLIFERATION , 2014, Retina.
[15] M. Ohji,et al. Ranibizumab and Aflibercept: Intraocular Pharmacokinetics and Their Effects on Aqueous VEGF Level in Vitrectomized and Nonvitrectomized Macaque Eyes. , 2015, Investigative ophthalmology & visual science.
[16] R. Kawasaki,et al. Short-term changes in choroidal thickness after aflibercept therapy for neovascular age-related macular degeneration. , 2015, American journal of ophthalmology.
[17] Soumya Jana,et al. Automated estimation of choroidal thickness distribution and volume based on OCT images of posterior visual section , 2015, Comput. Medical Imaging Graph..
[18] Seong Joon Ahn,et al. Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization. , 2015, Investigative ophthalmology & visual science.
[19] O. Strauß. Pharmacology of the retinal pigment epithelium, the interface between retina and body system. , 2016, European journal of pharmacology.
[20] R. Agrawal,et al. CHOROIDAL VASCULARITY INDEX IN CENTRAL SEROUS CHORIORETINOPATHY , 2016, Retina.
[21] Yong-Kyu Kim,et al. CHOROIDAL THICKNESS CHANGE AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN RETINAL ANGIOMATOUS PROLIFERATION AND ITS RECURRENCE , 2016, Retina.
[22] R. Agrawal,et al. CHOROIDAL VASCULARITY INDEX: A Novel Optical Coherence Tomography Based Parameter in Patients With Exudative Age-Related Macular Degeneration , 2017, Retina.
[23] R. Agrawal,et al. Choroidal vascular changes in age‐related macular degeneration , 2017, Acta ophthalmologica.
[24] R. Avery,et al. SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB , 2017, Retina.